{"cveId": "CVE-2021-26726", "cwe": ["CWE-78", "CWE-209", "CWE-272", "CWE-305", "CWE-330", "CWE-78", "CWE-209", "CWE-272", "CWE-305", "CWE-330"], "cvss": [{"baseScore": "8.8", "version": "3.1", "Attack Vector": "Adjacent", "Attack Complexity": "Low", "Privileges Required": "None", "User Interaction": "None", "Scope": "Unchaged", "Confidentiality Impact": "High", "Integrity Impact": "High", "Availability Impact": "High"}], "references": ["https://www.nozominetworks.com/labs/vulnerability-advisories/cve-2021-26726/", "https://www.valmet.com/about-us/research-and-development/vulnerabilityadvisories/"], "description": ["A remote code execution vulnerability affecting a Valmet DNA service listening on TCP port 1517, allows an attacker to execute commands with SYSTEM privileges This issue affects: Valmet DNA versions from Collection 2012 until Collection 2021."], "published": "2022-02-16T16:15:08.150", "state": "PUBLIC", "vendorName": ["Valmet DNA"], "productName": ["Valmet DNA"], "github": {"advisories": [], "commits": [], "pocAdvisorie": null, "repo": null, "info": {}}, "pocList": []}